We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$704M
AUM Growth
-$442M
Cap. Flow
-$488M
Cap. Flow %
-69.26%
Top 10 Hldgs %
31.51%
Holding
402
New
6
Increased
57
Reduced
64
Closed
261

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$13.4M
2
TOL icon
Toll Brothers
TOL
+$11.4M
3
UNH icon
UnitedHealth
UNH
+$5.17M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.49M
5
SGRY icon
Surgery Partners
SGRY
+$2.55M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$21.1M
2
PODD icon
Insulet
PODD
+$19M
3
LOW icon
Lowe's Companies
LOW
+$16.2M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$15.8M
5
KEYS icon
Keysight
KEYS
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 32.95%
2 Consumer Discretionary 18.04%
3 Technology 14.64%
4 Financials 13.2%
5 Industrials 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MFC icon
1
Manulife Financial
MFC
$73.3B
$33.5M 4.76%
1,006,314
+100,000
+11% +$1.91M
AAPL icon
2
Apple
AAPL
$4.5T
$26.2M 3.72%
135,186
+3,717
+3% +$648K
UNH icon
3
UnitedHealth
UNH
$371B
$22.7M 3.22%
47,229
+10,575
+29% +$5.17M
INMD icon
4
InMode
INMD
$873M
$20.9M 2.97%
560,557
-6,000
-1% -$210K
IQV icon
5
IQVIA
IQV
$39.8B
$20.9M 2.96%
92,824
-20,428
-18% -$4.1M
MSFT icon
6
Microsoft
MSFT
$3.76T
$20.7M 2.94%
60,849
+2,577
+4% +$808K
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$133B
$20.4M 2.89%
57,844
+10,359
+22% +$3.49M
TMO icon
8
Thermo Fisher Scientific
TMO
$222B
$19.9M 2.82%
38,077
-57
-0.1% -$30.8K
SCI icon
9
Service Corp International
SCI
$11.4B
$19.4M 2.75%
300,000
-20,000
-6% -$1.34M
BC icon
10
Brunswick
BC
$5.21B
$17.3M 2.46%
200,000
– –
LLY icon
11
Eli Lilly
LLY
$1.1T
$16.8M 2.39%
35,890
-9,536
-21% -$4M
MRK icon
12
Merck
MRK
$323B
$16M 2.27%
138,405
-29,425
-18% -$3.34M
THO icon
13
Thor Industries
THO
$4.14B
$15.5M 2.2%
150,000
-25,000
-14% -$2.11M
AMP icon
14
Ameriprise Financial
AMP
$49.2B
$15.2M 2.16%
45,702
– –
LH icon
15
Labcorp
LH
$26.1B
$14.6M 2.08%
70,635
-11,640
-14% -$2.26M
RCL icon
16
Royal Caribbean
RCL
$82.4B
$13.7M 1.94%
131,981
+275
+0.2% +$21.6K
CHE icon
17
Chemed
CHE
$7.18B
$13.5M 1.92%
25,000
– –
ELS icon
18
Equity Lifestyle Properties
ELS
$12.5B
$13.5M 1.92%
202,232
-15,000
-7% -$999K
TOL icon
19
Toll Brothers
TOL
$14B
$13.4M 1.91%
+170,000
New +$11.4M
GL icon
20
Globe Life
GL
$14.2B
$13.2M 1.88%
120,579
– –
RMD icon
21
ResMed
RMD
$31.9B
$13.2M 1.87%
+60,254
New +$13.4M
HOLX
22
DELISTED
Hologic
HOLX
$13M 1.85%
160,851
-40,429
-20% -$3.3M
NVDA icon
23
NVIDIA
NVDA
$5.27T
$9.86M 1.4%
233,030
-44,200
-16% -$1.47M
AMZN icon
24
Amazon
AMZN
$3T
$9.61M 1.36%
73,705
+3,767
+5% +$430K
EVH icon
25
Evolent Health
EVH
$444M
$9.09M 1.29%
300,000
– –
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q2 2023 Portfolio in Review

As of Q2 2023, Lombard Odier Asset Management (Switzerland) held 402 positions worth $704M, down 39% from $1.15B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Lombard Odier Asset Management (Switzerland) withdrew a net $488M in Q2 2023, closing 261 positions and reducing 64 holdings. Its most notable exit was Insulet, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in ResMed worth $13.2M.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2023 buy was ResMed: 60,254 shares worth $13.2M.
  • Lombard Odier Asset Management (Switzerland) added most to UnitedHealth in Q2 2023, an estimated $5.17M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2023 reduction was DexCom, cutting an estimated $21.1M.
  • Lombard Odier Asset Management (Switzerland) fully exited Insulet in Q2 2023, selling an estimated $19M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 32% of its $704M portfolio in Q2 2023.
  • Lombard Odier Asset Management (Switzerland) opened 6 new positions and closed 261 in Q2 2023.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 39% quarter-over-quarter to $704M.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.